Molecular Allergy Testing in Istanbul

What Is Molecular Allergy Testing?

Molecular allergy testing investigates IgE sensitisation to defined allergen molecules rather than looking only at an allergen source as a whole. It is also called component-resolved diagnosis, component testing or CRD. In clinical practice, these results can add detail to an allergy assessment when there is a specific question to resolve.

For example, a report labelled peanut describes a source containing several different proteins. Component testing can investigate selected proteins from that source. The extra detail still needs to be connected with the patient’s symptoms and exposures. At Istanbul Allergy, children and adults can enquire about a consultation and suitable molecular testing. The aim is an understandable explanation and care plan, rather than a longer list of technical names without a clear clinical purpose.

Extracts and Components: Understanding the Difference

An extract-based test assesses sensitisation to material representing an allergen source. A component assay assesses a defined allergenic molecule from that source. Different components can belong to different protein families, which helps explain why two patients with a positive result to the same source may have different clinical histories.

Ask the clinician to identify whether your previous report tested extracts, components or both. A result described simply as a blood allergy test may not make that distinction clear. Bring the full report instead of copying only the positive lines. Knowing what was actually measured helps decide whether further detail is relevant. Molecular testing should address an uncertainty that matters to care; it is not automatically required whenever a conventional test has already established a clear and useful assessment.

Which Clinical Questions Can It Help Address?

Component testing may help clarify selected food-allergy questions, distinguish some cross-reactive patterns and support interpretation when conventional results are difficult to reconcile with symptoms. Its role depends on the allergen and evidence for the individual component. It is not a universal replacement for existing assessment methods.

Useful questions include why several related foods test positive, whether pollen sensitisation may help explain a food result, or whether additional information could inform a proposed assessment. Ask what decision would change if the component is positive or negative. If neither result would affect care, discuss why the test is being proposed now. A good consultation should establish the purpose first and then select an appropriate assay, instead of starting with a large panel and searching afterwards for something to explain.

Why Your Reaction History Still Comes First

Laboratory sensitisation and clinical allergy are not interchangeable. The history provides the link between an antibody result and symptoms during real exposure. A molecular report cannot independently establish what happened during a reaction or replace a clinical assessment of that episode.

Prepare a concise description of each important event: the suspected food or exposure, approximate timing, symptoms, treatment and outcome. Include foods eaten normally as well as those avoided. Bring emergency-care records if available. Describe whether the food was raw, cooked or part of a mixed meal, without deliberately repeating an exposure to gather evidence. For respiratory concerns, note seasons, pets and work circumstances. These details help the clinician decide whether components are likely to add useful information to the existing picture.

Cross-Reactivity and Multiple Positive Results

Some allergenic proteins share structural similarities across different sources. IgE directed at related molecules can therefore contribute to a pattern of several positive tests. This does not automatically mean that every positive source causes a separate clinical allergy.

If you have a long report, ask which findings may represent related sensitisation and which are supported by the symptom history. A positive result should not be ignored simply because cross-reactivity exists, but neither should every related food be removed without review. Tell the clinician which foods are tolerated and which were stopped only because of screening. The practical task is to make the pattern understandable and identify what needs management, what remains uncertain and whether another assessment would change the advice.

Pollen Food Syndrome and Oral Symptoms

Pollen food syndrome can occur when sensitisation to pollen proteins is associated with reactions to related proteins in plant foods. The history often involves oral symptoms with particular foods, but the presentation needs individual assessment. Reactions involving nuts, soy or atypical symptoms may require more investigation than a straightforward history alone.

Describe the exact symptoms instead of assuming that any mouth itching is automatically mild or that every plant-food reaction is pollen-related. Tell the clinician whether raw and cooked forms differ, whether symptoms extended beyond the mouth and what treatment was needed. Molecular testing may help clarify a particular question, but it cannot authorise a home trial of a food involved in a concerning reaction. Ask for an individual explanation and clear advice about what should continue to be avoided while assessment is completed.

Protein Families: Why the Names Matter

Reports may refer to storage proteins, PR-10 proteins, profilins or lipid transfer proteins. These terms describe groups of allergen molecules with different biological characteristics. Their clinical meaning depends on the individual protein, exposure and patient, so a family name should not be translated into a universal safe-or-dangerous category.

Ask for a plain-language explanation of the proteins that matter in your own report. You do not need to learn every code to understand the care plan. The relevant discussion is whether the finding fits your history and whether it changes a decision about precautions, further assessment or treatment. Avoid using a general table online to decide that a raw, cooked or processed food is safe for you. That conclusion needs an appropriate clinical assessment rather than an assumption based only on the family label.

Examples explain terminology, not a diagnosis or confirmation of the clinic’s current panel. No row establishes whether a food is safe for an individual patient.

Peanut Components: Ara h 2 and Ara h 8

Ara h 2 and Ara h 8 illustrate why molecular detail can matter. Ara h 2 is a major peanut allergen used in assessing suspected primary peanut allergy, whereas isolated Ara h 8 sensitisation can reflect a pollen-related pattern. The interpretation still depends on the actual history and the rest of the assessment.

A component name is not a home-challenge instruction or a guarantee about future severity. If peanut has caused a reaction, describe the event and keep following the existing management plan until reviewed. If peanut is eaten normally but a test is positive, explain that clearly. Ask what the additional component result would change and whether any uncertainty remains afterwards. Our Food Allergy Treatment page describes the broader pathway beyond the laboratory report.

Hazelnut and Other Tree Nut Questions

Tree nut assessment may involve distinguishing a primary food-allergy pattern from sensitisation linked to pollen or other cross-reactive proteins. Components can support selected risk and diagnostic discussions, but findings must be interpreted with the patient’s history. A result for one nut does not automatically define clinical allergy to every other nut.

Provide the name of the nut involved, how it was eaten and which other nuts are normally tolerated. Bring reports showing the individual extracts and components rather than a summary saying mixed nuts positive. If all nuts have been avoided after a reaction to one, ask how the scope of avoidance should be assessed. Do not independently reintroduce a nut linked to a convincing reaction. The plan should explain which questions have been answered and what further steps, if any, are needed for the remaining foods.

Milk and Egg Components

Milk and egg contain several allergenic proteins. Components such as Bos d 8 for milk and Gal d 1 for egg may contribute to selected clinical assessments. A result does not by itself establish that a particular preparation is tolerated or that allergy has resolved.

Tell the clinician which forms have caused symptoms and which are currently eaten under an agreed plan. Describe baked products separately from less extensively heated foods, without assuming that heating makes every product safe. Ask whether component information would change the next decision or whether another assessment is needed. Do not start a milk or egg ladder, increase an existing amount or conduct a food challenge simply because one molecular value has fallen. Assessment of tolerance and the appropriate setting should remain part of the clinician’s plan.

Lipid Transfer Proteins and Cofactors

Lipid transfer protein sensitisation can be relevant in selected plant-food allergy assessments. Pru p 3, a peach component, is one marker used in investigating this pattern. The clinical history may include the influence of cofactors, such as exercise or alcohol, and requires careful interpretation rather than a diagnosis based on one marker.

Record the circumstances of reactions as accurately as possible. Explain what else was happening around the meal, including activity and medicines, but do not recreate the combination to test your theory. Ask which foods or circumstances actually need precautions and whether further assessment is necessary. A positive marker is not a reason to remove every plant food without clinical advice. The aim is to understand the individual pattern and develop a proportionate plan rather than expand restrictions from a list of related proteins.

Molecular Testing for Respiratory Allergy Questions

For a patient with several positive airborne-allergen results, the useful question may be which sensitisation best fits the symptom pattern and exposure. Molecular information can be considered as part of that review when it is likely to clarify an unresolved issue. It should not replace an appropriate assessment of nasal symptoms or breathing problems.

Describe seasons, places and activities associated with symptoms. Explain what happens around animals and whether symptoms change between countries. If you have asthma, bring the treatment history and describe current control. Ask why a component test is proposed, what its result would add to existing extract or skin testing, and how that information would be used. A detailed report is most useful when the clinician can connect it to a specific decision, rather than presenting every positive pollen or animal result as equally relevant.

Individual Component Tests and Multiplex Panels

Component testing can be performed for selected individual allergens or through assays measuring many allergens together. A multiplex format can reveal a broad sensitisation pattern, but broad coverage can also create findings that are difficult to interpret without the history. More measured items do not automatically produce a better diagnosis.

Ask which format is proposed and what clinical question justifies its scope. If a few selected components can resolve the uncertainty, discuss whether a larger panel adds value. If a broader investigation is appropriate, confirm how unexpected findings will be reviewed. The explanation should include what the test does not cover as well as what it measures. Avoid choosing a test solely because a large headline number sounds more comprehensive than another product’s list.

Test Names, Platforms and the Actual Panel

Molecular allergy testing is a diagnostic approach rather than one identical product. Laboratories may use different platforms, combinations of extracts and components, reporting formats and assay versions. Before booking a named test, confirm the actual panel and whether it includes the proteins relevant to your question.

This page does not claim that every commercially available molecular assay is offered at the clinic. Ask the team which option is currently available and how it differs from any previous test. If you have a report from another country, send the full document so that unnecessary duplication can be considered. Confirm the sample requirements, reporting arrangements and whether clinician interpretation is included. Product names alone should not replace a clear description of what will be measured and why it is being requested.

Molecular Allergy Testing in Children

Children can have an allergy assessment when clinically indicated, and blood testing may be part of that process. The decision to add components should address a relevant question in the child’s history rather than use a broad panel as routine screening for every possible food allergy.

Give the child’s age, current diet and previous reaction history when enquiring. Explain how many foods have been excluded and why. If the child is anxious about blood collection, ask about practical preparation and comfort measures. A useful review should explain the meaning of results to caregivers in clear language and distinguish confirmed management needs from uncertainty. Do not make new restrictions from a report before clinical interpretation, particularly when they affect foods important to the child’s everyday nutrition.

Adults With Multiple Sensitisations or Unclear Reactions

Adults may seek a molecular assessment because conventional results show several positives, the suspected trigger remains uncertain or a food reaction does not fit an existing explanation. Bring the history and reports that created the uncertainty. A detailed review may be more valuable than immediately repeating a large panel.

Explain which foods and activities are currently tolerated, what precautions you follow and how the problem affects work or travel. If symptoms have changed, describe the change rather than assuming an old diagnosis still explains everything. Ask what the appointment can realistically clarify and whether another specialist assessment is appropriate. A molecular report should contribute to an individual decision; it cannot replace assessment of symptoms that are unrelated to the IgE-mediated questions the assay was designed to investigate.

Preparation: Eating and Medicines Before Sampling

Allergy blood testing alone generally does not require fasting. However, other investigations arranged at the same visit may have different requirements. Obtain instructions for the actual appointment and do not deliberately eat a suspected allergen to prepare for sampling.

Provide the complete medication list, including antihistamines, biological treatment and any recent changes. Do not stop prescriptions independently. If skin testing is also planned, ask which preparation instructions apply to that part of the visit, because the requirements are not necessarily the same. Keep following any prescribed food-avoidance and emergency plan until it is reviewed. If the appointment is being arranged from abroad, clarify preparation before travelling so that the visit can be planned around the patient’s circumstances rather than an assumption about one universal protocol.

What Happens During the Blood Test?

A trained professional takes a blood sample using appropriate collection equipment. Brief discomfort or bruising can occur. Tell the person collecting the sample if you have fainted during previous blood tests, have difficult veins or take medicines that affect bleeding.

The laboratory then performs the requested analysis; the allergenic material is used in the assay rather than fed to the patient as part of routine molecular blood testing. Ask how much time to allow and whether other samples are required for any additional investigation. For children, discuss preparation in advance and bring a familiar distraction if helpful. Before leaving, check how and when results will be reviewed. Obtaining the sample is not the same as completing the clinical interpretation of a complex sensitisation pattern.

Reading Component Names, Numbers and Flags

A report may list allergen sources, molecular codes, numerical values and laboratory flags. Start by identifying the assay and what each line represents. A positive flag does not mean every food source on the report must be avoided, and a numerical class is not a percentage prediction of reaction severity.

Ask for a plain-language explanation organised around your clinical questions. Which findings fit the history? Which may reflect cross-reactivity? Which are unexpected and need further thought? Bring the complete report, including units, method and collection date. A cropped image can omit details necessary for review. If software supplies an automated summary, ask the clinician to explain how its suggestions fit the actual symptom history. The report should support a conversation and an individual plan rather than become a standalone set of instructions.

Positive and Negative Results Have Limits

A positive IgE result indicates sensitisation and needs clinical context. A negative result does not exclude every allergy or every reason for symptoms. The included molecules, assay performance and the suspected reaction mechanism all matter when deciding what a report can answer.

Ask whether the relevant protein was actually measured and whether further assessment would change care. Do not independently retry a food or medicine involved in a serious reaction because a panel is negative. Equally, do not add restrictions solely because an unexpected component is flagged. A careful review distinguishes what is established, what remains possible and what is not addressed by the test. That distinction is particularly important when a broad report creates more questions than the original targeted investigation.

Can Molecular Testing Predict Anaphylaxis?

Certain component patterns can contribute to clinical risk assessment, but no report can guarantee the severity of a future reaction for an individual patient. Conventional skin and IgE blood tests cannot independently predict exactly how severely a person will react to a food.

The discussion should consider the patient’s history and management needs rather than turn protein families into fixed severity labels. Ask what the finding changes about precautions and what it does not change. If adrenaline has been prescribed, do not discontinue it because a report appears reassuring. If the result causes anxiety, ask the clinician to explain the uncertainty directly. The aim is practical, proportionate advice: what to avoid, what to do if a reaction occurs and whether a further supervised assessment would answer the remaining question.

Does It Replace an Oral Food Challenge?

Component testing can refine an assessment, but it does not remove the need for every supervised oral food challenge. In selected cases, a medically supervised challenge is still needed to establish the clinical relevance of a food result or clarify tolerance. The decision depends on the individual situation.

Ask why a challenge is or is not being considered and what alternatives can reasonably clarify the question. Do not attempt a small home trial as a substitute for a recommended supervised procedure. Confirm the service scope and preparation separately if a challenge is proposed. Patients travelling for testing should establish whether the visit is for consultation and blood collection only or whether another procedure would require a different date, setting or care arrangement. These are separate clinical and practical decisions.

Can Results Help With Treatment Planning?

The clinical assessment may lead to discussion of relevant avoidance measures, symptom treatment or suitability for an immunotherapy pathway. For respiratory allergy, allergen relevance and the wider clinical situation matter when considering immunotherapy; a positive component alone does not establish eligibility.

Ask which decision the additional molecular information has helped resolve. If treatment is discussed, confirm its purpose, availability, expected follow-up and arrangements for continuing care after returning home. Food-allergy treatment decisions also require a full assessment rather than a panel-based promise of suitability or success. Our Allergy Immunotherapy and Oral Immunotherapy pages explain those separate pathways. The value of testing lies in supporting an appropriate plan, not guaranteeing access to a specific treatment.

Molecular IgE Testing Is Different From IgG Panels

Molecular allergy assays measure IgE sensitisation to selected components. They are not the same as IgG or IgG4 food panels. Major allergy organisations advise against using food IgG testing to diagnose food allergy or food intolerance; the antibody types and proposed interpretations should not be confused.

If you already have a report described as intolerance, sensitivity or comprehensive testing, bring the full document. Ask what was actually measured and which conclusions are justified. A large list does not automatically explain digestive symptoms or support removing every flagged food. If the problem does not fit an IgE-mediated question, another assessment pathway may be appropriate. The consultation should clarify that distinction instead of assuming that the most technically detailed antibody report is necessarily the answer to every symptom.

Comparing Reports and Deciding Whether to Repeat Testing

Different allergy assay methods may not yield directly comparable numerical results, even when the units look similar. Provide the platform, dates and full reports before drawing conclusions about a change in sensitisation. Interpretation should include the clinical history and any relevant treatment changes.

Ask what a repeat test would help decide now. Repeating a large panel simply to compare coloured flags can create more uncertainty if the method or panel changed. A focused follow-up question may be more useful. Keep the symptom timeline alongside the laboratory documents: what exposures occurred, what was tolerated and why management changed. If you are seeking a second opinion from abroad, providing complete records can help the clinician assess whether existing information is sufficient before requesting another sample.

Reporting Times and Your Results Consultation

The time required depends on the assay, laboratory arrangements and whether specialised work is needed. Confirm the current estimate for the actual test with Istanbul Allergy. This page does not promise a fixed reporting interval for every molecular platform or guarantee that all findings will be available before a short visit ends.

Ask who will review the report, whether a separate consultation is included and how you will receive a copy. Establish whether a later discussion can take place online after returning home. A report containing many components needs an explanation tied to your symptoms and decisions. Before booking travel, clarify whether the initial appointment is for assessment, sampling, review of an existing report or several of these activities. Clear arrangements help ensure that obtaining a detailed laboratory report leads to a useful clinical discussion.

Planning Molecular Allergy Testing in Istanbul

Contact Istanbul Allergy with the patient’s age, main symptoms, previous test history and preferred dates. Explain the unresolved question: several positive foods, uncertainty about pollen cross-reactivity or another specific concern. Ask about a consultation with Prof. Dr. Ahmet Akçay and confirm the proposed assessment before arranging travel.

Our address is Harbiye Mah., Teşvikiye Cad., Karaosmanoğlu Apartmanı, No: 37, Floor 3, Şişli, Istanbul, opposite City’s Shopping Mall. Confirm consultation language, arrival details and how records should be shared; ask whether translation is needed. The Plan Your Visit page offers practical preparation information. A website available in several languages does not itself confirm every consultation-language arrangement, so establish the support you need directly with the team.

Costs, Online Review and Continuing Care Abroad

Ask what the consultation and proposed assay cost, whether individual components and larger panels are priced differently, and whether interpretation or follow-up is included. Confirm the quotation for the actual plan rather than assuming a general testing fee includes every possible investigation.

An online consultation may support selected history discussions, review of an existing molecular report or follow-up planning. Sampling still requires appropriate in-person arrangements, and some clinical questions require examination or another procedure. If you live abroad, ask how recommendations will be shared with your usual clinician. Before the review ends, make sure you understand what is confirmed, what remains uncertain, which precautions continue and what the next decision involves. That explanation is the practical outcome to seek from a detailed molecular assessment.

Urgent Symptoms Need Immediate Care

Molecular testing is a planned investigation, not treatment for an ongoing severe reaction. Seek immediate emergency care for suspected anaphylaxis, including breathing difficulty, throat or tongue swelling, collapse or rapidly worsening symptoms after an exposure. In Turkey, call 112 and follow your prescribed emergency plan, including adrenaline if prescribed for the situation.

Do not wait for a blood result, appointment or WhatsApp reply when urgent care is needed. After emergency treatment, keep the documents and arrange the recommended follow-up. The later consultation can then consider which investigations may help clarify the event. A reassuring previous panel should not be used to dismiss acute concerning symptoms, and a request for a more detailed test should never delay emergency assessment. Tell the reviewing clinician what happened and what treatment was given.

YOUR QUESTIONS

Molecular Allergy Testing: Frequently Asked Questions

Scientific Sources & Further Reading

General information does not establish an individual diagnosis. Test selection, panel availability, preparation, reporting and follow-up are confirmed for the actual appointment.

1. EAACI: Molecular Allergology User’s Guide 2.0. ↗
2. BSACI: Component-resolved diagnosis. ↗
3. AAAAI: Component-resolved diagnostics for tree nut allergy. ↗
4. BSACI: Diagnosis and management of pollen food syndrome. ↗
5. BSACI: Plant food allergy and lipid transfer proteins. ↗
6. BSACI: Peanut, tree nut and seed allergy. ↗
7. BSACI: Milk and egg allergy. ↗
8. ACAAI/AAAAI: Pearls and pitfalls of diagnostic allergy testing. ↗
9. ACAAI: Food allergy testing and diagnosis. ↗
10. MedlinePlus: Allergy blood testing. ↗
11. NHS: Blood tests. ↗
12. ACAAI: Testing children and infants. ↗
13. AAAAI: Allergy testing. ↗
14. AAAAI: IgG food testing. ↗
15. AAAAI: Allergy shots and immunotherapy. ↗
16. NHS: Anaphylaxis. ↗